MALAT1 and non-small cell lung carcinoma: Taken together, based on the literature, some miRNAs such as miR-142-3p and miR-101-3p can target MALAT1 for degradation, thereby negatively inhibiting the lever of MALAT1 in NSCLC (44, 53).